Valerie A. Holst, M.D.
Cytopathology Physician · Boise, ID
Valerie A. Holst, M.D. is a cytopathology physician with a practice address in Boise, Idaho, and NPI 1861446064, issued on May 20, 2006. Check the license (Idaho M8019, as entered in NPPES) on the Idaho Board of Medicine; the Medicare figures below come from public CMS files.
- Name
- Valerie A. Holst
- Credential
- M.D.
- Primary taxonomy
- Cytopathology Physician 207ZC0500X
- License number
- M8019 ID
Self-reported in NPPES; status is on the state search - Practice location
- 190 E Bannock St, Boise, ID 83712
- Phone
- (208) 381-2367
- Enumerated
- May 20, 2006
- Record last updated
- Sep 11, 2025
- Medicare enrollment
- Enrolled (PECOS I20100714000465); accepts Medicare assignment
- Entity
- Type 1 · individual
All 1 in Idaho → Look up another NPI →
Also registered at 190 E Bannock St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Aaron Ackerson, ACNPC-AGAcute Care Nurse Practitioner1982329751
- Jarren Adam, DOEmergency Medicine Physician1295484699
- Sariah AdamsRegistered Nurse1801737978
- Grace Adamson, MDFamily Medicine Physician1497246136
- J Thomas Ahlquist, MDEmergency Medical Services (Emergency Medicine) Physician1598703902
- Dawn Aiken, NPFamily Nurse Practitioner1295175313
Verify Valerie A. Holst in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersIdaho Board of Medicine
Search for license M8019Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
The practice group's MIPS final score for 2023 (Medicare payment program): 91.5 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Bills Medicare through one group practice
- Diagnostic Pathology Services IncNampa, ID
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Cytopathology Physician providers in Idaho
There are 1 cytopathology physician records in Idaho.
All 1 in Idaho → Every provider in Boise → Cytopathology Physician nationwide →
Common questions
What is Valerie A. Holst, M.D.'s NPI number?
Valerie A. Holst, M.D.'s National Provider Identifier (NPI) is 1861446064, issued on May 20, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Valerie A. Holst, M.D. located?
The NPPES record lists a practice address at 190 E Bannock St, Boise, ID, 83712. Phone: (208) 381-2367. Providers update this record themselves, so call before visiting.
How can I verify Valerie A. Holst, M.D.'s license?
NPPES lists Idaho license number M8019, as entered by the provider. Search the Idaho Board of Medicine at https://dopl.idaho.gov/bom/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
What is Valerie A. Holst, M.D.'s MIPS final score?
The 2023 MIPS final score is 91.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.